PRMT5 knockdown down-regulated PI3K/AKT/mTOR signaling in an influx of cancer cells, including bladder cancer, lymphoma, and Non-small-cell lung carcer (NSCLC) (181–183). This evidence concerns the gene PRMT5 and cancer.